New Study Shows Key Protein Works Together with VEGF to Stimulate Abnormal Blood Vessel Growth, Targeting Both Could More Effectively Treat Cancer and Other Diseases
NEW YORK–(ENEWSPF)–September 10, 2012 — A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal — such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
Their study,…
